News in the Life Sciences Industry

STOCKHOLM, May 7, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today announces that data from the investigator-initiated study evaluating the effects of remetinostat in basal cell carcinoma patients, will be presented during the 2019 Society for Investigative Dermatology... Read more ››

STOCKHOLM, May 7, 2019 /PRNewswire/ -- First quarter, January - March 2019

STOCKHOLM, May 7, 2019 /PRNewswire/ --

STOCKHOLM, May 7, 2019 /PRNewswire/ -- Today Tuesday May 7, at 04.00 p.m. CET IRRAS will host a conference call and an online presentation of its Q1 2019 interim report (which was published earlier today 08.00 a.m. CET).

STOCKHOLM, May 7, 2019 /PRNewswire/ -- Bioservo Technologies AB (publ) (Nasdaq First North: BIOS) announced today that the company introduces the next version of Ironhand® that offers significant improvements for the user. The all-new Ironhand® includes important refinements such as increased... Read more ››

GOTHENBURG, Sweden , May 7, 2019 /PRNewswire/ -- A pilot project, the first of its kind in Sweden, is currently underway in Region Värmland to connect Getinge's digital patient flow system INSIGHT to Torsby Hospital, two clinics and two municipal businesses. The system will provide an easy... Read more ››

STOCKHOLM, May 6, 2019 /PRNewswire/ -- On May 8, 2019, at 07:00am CET, Calliditas Therapeutics ("Calliditas") will publish its business update for the first quarter 2019. The company will also host a telephone conference, which will include a presentation of the results, on the same day at 3:00pm... Read more ››

STOCKHOLM, May 6, 2019 /PRNewswire/ --The study, which evaluated standard hormonal therapies in metastatic breast cancer, used the DiviTum® blood test as a non-invasive tool to monitor therapy efficacy. A total of 244 patients had their blood samples analyzed with DiviTum® and the study found... Read more ››

STOCKHOLM, May 6, 2019 /PRNewswire/ -- Medivir AB (Nasdaq Stockholm: MVIR) today informs that new data from the phase II program of MIV-711, has been presented as a poster during the Osteoarthritis Research Society International (OARSI) world congress. The poster title was Safety and... Read more ››

STOCKHOLM, May 3, 2019 /PRNewswire/ -- IRRAS AB (Nasdaq First North Premier: IRRAS), a commercial-stage medical-technology company, today announced that the company's nomination committee recommends Ms. Catherine Gilmore-Lawless to be a new IRRAS board member.

STOCKHOLM, May 3, 2019 /PRNewswire/ -- Enzymatica has now finalized the enrolment to its prospective double-blind, placebo-controlled multicentre study to evaluate the effects of ColdZyme® on the common cold. In total about 700 patients have been enrolled at ten study centres... Read more ››